Tonya Winders, MBA, CEO and president of the Allergy & Asthma Network, highlights what she is looking forward to at the European Respiratory Society (ERS) International Congress 2021.
Tonya Winders, MBA, CEO and president of the Allergy & Asthma Network, highlights what she is looking forward to at the European Respiratory Society (ERS) International Congress 2021.
Transcript:
What is your session on asthma guidelines going to entail?
So, I'm excited to attend the European Respiratory Society meeting and to participate in this particular session, which highlights the health care system failures for patients that are living with chronic respiratory disease. So, I'll be bringing forth the patient perspective on how current national policies are lacking for so many patients across the world to ensure that they're getting adequate diagnosis, treatment, and management of their chronic respiratory disease.
What other sessions are you looking forward to hearing about?
Well, it's always exciting to be with the world's leaders at the ERS meetings and to hear the latest science when it comes to chronic respiratory disease. So, I'm certainly looking forward to the sessions on asthma and COPD [chronic obstructive pulmonary disease]. I'm very interested in the COVID-19 long haul and how it may be impacting this community specifically. Again, we were seeing that and hearing that directly from the patient community on a daily basis. So, learning what the latest science and thoughts are on COVID-19 long haul and its relationship to asthma and COPD, specifically, is what I'm looking forward to.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen